Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 3, 2006, Pages 705-712

  Li, Shengjin ^a   Kim, Jae Sung ^b   Kim, Jin Man ^a   Cho, Moon June ^a   Yoon, Wan Hee ^a   Song, Kyu Sang ^a   Yeo, Seung Gu ^a   Kim, Jun Sang ^a  

^a Chungnam National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Epidermal growth factor receptor; Preoperative chemoradiation; Rectal cancer

Indexed keywords

BIOMEDICAL ENGINEERING; BIOPSY; CHEMOTHERAPY; HEALTH CARE; IMMUNOLOGY; PATIENT TREATMENT; TUMORS;

EPIDERMAL GROWTH FACTOR RECEPTOR; MULTIVARIATE ANALYSIS; PREOPERATIVE CHEMORADIATION; RECTAL CANCER;

RADIOTHERAPY;

EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECTUM CANCER; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY; UNIVARIATE ANALYSIS;

AGED; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33646941041     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.013     Document Type: Article

References (41)

1. McCall J.L., Cox M.R., and Wattchow D.A. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 10 (1995) 126-132
2. Abulafi A.M., and Williams N.S. Local recurrence of colorectal cancer. The problem, mechanisms, management and adjuvant therapy. Br J Surg 81 (1994) 7-19
3. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312 (1985) 1465-1472
4. Chen E.T., Mohiuddin M., Brodovsky H., et al. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 30 (1994) 169-175
5. Janjan N.A., Khoo V.S., Abbruzzese J., et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer. The M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 44 (1999) 1027-1038
6. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
7. Minsky B.D., Cohen A.M., Enker W.E., et al. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 37 (1997) 289-295
8. Kim J.S., Kim J.S., Cho M.J., et al. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 54 (2002) 403-408
9. Rich T., Gunderson L.L., Lew R., et al. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 52 (1983) 1317-1329
10. Bjerkeset T., Morild I., Mork S., et al. Tumor characteristics in colorectal cancer and their relationship to treatment and prognosis. Dis Colon Rectum 30 (1987) 934-938
11. Thibodeau S.N., Bren G., and Schaid D. Microsatellite instability in cancer of the proximal colon. Science 260 (1993) 816-819
12. Zeng Z.S., Sarkis A.S., Zhang Z.F., et al. p53 nuclear overexpression. An independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol 12 (1994) 2043-2050
13. Johnston P.G., Fisher E.R., Rockette H.E., et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12 (1994) 2640-2647
14. Hackel P.O., Zwick E., Prenzel N., et al. Epidermal growth factor receptors. Critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11 (1999) 184-189
15. Zwick E., Hackel P.O., Prenzel N., et al. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci 20 (1999) 408-412
16. Grandis J.R., and Tweardy D.J. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53 (1993) 3579-3584
17. Schlessinger J., Schreiber A.B., Levi A., et al. Regulation of cell proliferation by epidermal growth factor. CRC Crit Rev Biochem 14 (1983) 93-111
18. Moyer J.D., Barbacci E.G., Iwata K.K., et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res 57 (1997) 4838-4848
19. Liebmann C. Regulation of MAP kinase activity by peptide receptor signalling pathway. Paradigms of multiplicity. Cell Signal 13 (2001) 777-785
20. Salomon D.S., Brandt R., Ciardiello F., et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19 (1995) 183-232
21. Starling N., and Cunningham D. Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers. Present and future directions. Curr Opin Oncol 16 (2004) 385-390
22. Goldstein N.S., and Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma. Implications for a standardized scoring system. Cancer 92 (2001) 1331-1346
23. Nicholson R.I., Gee J.M., and Harper M.E. EGFR and cancer prognosis. Eur J Cancer 37 Suppl. 4 (2001) S9-S15
24. Giralt J., de las Heras M., Cerezo L., et al. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy. A multicenter, retrospective analysis. Radiother Oncol 74 (2005) 101-108
25. Fernebro E., Bendahl P.O., Dictor M., et al. Immunohistochemical patterns in rectal cancer. Application of tissue microarray with prognostic correlations. Int J Cancer 111 (2004) 921-928
26. Burgering B.M., and Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 (1995) 599-602
27. Buettner R., Mora L.B., and Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8 (2002) 945-954
28. Ang K.K., Berkey B.A., Tu X., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62 (2002) 7350-7356
29. Chua D.T., Nicholls J.M., Sham J.S., et al. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 11-20
30. Schmidt-Ullrich R.K., Valerie K.C., Chan W., et al. Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. Int J Radiat Oncol Biol Phys 29 (1994) 813-819
31. Kavanagh B.D., Dent P., Schmidt-Ullrich R.K., et al. Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. Radiat Res 149 (1998) 579-587
32. Akimoto T., Hunter N.R., Buchmiller L., et al. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res 5 (1999) 2884-2890
33. Lammering G., Hewit T.H., Hawkins W.T., et al. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. J Natl Cancer Inst 20 93 (2001) 921-929
34. Liang K., Ang K.K., Milas L., et al. The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Biol Phys 57 (2003) 246-254
35. Shibata T., Kawano T., Nagayasu H., et al. Enhancing effects of epidermal growth factor on human squamous cell carcinoma motility and matrix degradation but not growth. Tumour Biol 17 (1996) 168-175
36. Engebraaten O., Bjerkvig R., Pedersen P.H., et al. Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int J Cancer 53 (1993) 209-214
37. Stumm G., Eberwein S., Rostock-Wolf S., et al. Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis. Int J Cancer 69 (1996) 17-22
38. Radinsky R., Risin S., Fan D., et al. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1 (1995) 19-31
39. Kopp R., Rothbauer E., Mueller E., et al. Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels. Dis Colon Rectum 46 (2003) 1391-1399
40. McKay J.A., Murray L.J., Curran S., et al. Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. Eur J Cancer 38 (2002) 2258-2264
41. Chakravarti A., Winter K., Wu C.L., et al. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy. A report from the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 62 (2005) 309-317